Testim Gel
Endo faces industry-first FDA call to pull its opioid painkiller
Misuse of Opana ER has been associated with a ‘serious’ HIV and hep C outbreaks
Endo buys Par for $8bn as M&A mania marches on
Acquisitionwill make Endo the fifth largest generics company in the US
Endo’s $2.2bn bid for Auxilium Pharma could thwart QLT deal
Auxilium in the $345m process of acquiring Canadian biotech company
Endo opts for Ogilvy PR
Agency will provide PR support for Endo’s men’s health and pain management business
Endo to collaborate with India-based CRO GVK Biosciences
Will develop small molecule against undisclosed target in pain